Hypera Résultats passés
Passé contrôle des critères 1/6
Les bénéfices de Hypera ont diminué à un taux annuel moyen de -6.8%, tandis que le secteur Pharmaceuticals a vu ses bénéfices augmenter de en à 8.2% par an. Les revenus ont augmenté de en à un taux moyen de 8.2% par an. Le rendement des capitaux propres de Hypera est 9.5% et ses marges nettes sont de 15.5%.
Informations clés
-6.77%
Taux de croissance des bénéfices
-6.79%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 12.39% |
| Taux de croissance des recettes | 8.19% |
| Rendement des fonds propres | 9.51% |
| Marge nette | 15.53% |
| Prochaine mise à jour des résultats | 06 Aug 2026 |
Mises à jour récentes des performances passées
Article d’analyse • May 07
Hypera's (BVMF:HYPE3) Solid Profits Have Weak Fundamentals
Hypera S.A.'s ( BVMF:HYPE3 ) robust earnings report didn't manage to move the market for its stock. We did some...Article d’analyse • Nov 05
Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think
Hypera S.A.'s ( BVMF:HYPE3 ) stock showed strength, with investors undeterred by its weak earnings report. We think...Recent updates
Article d’analyse • May 07
Hypera's (BVMF:HYPE3) Solid Profits Have Weak Fundamentals
Hypera S.A.'s ( BVMF:HYPE3 ) robust earnings report didn't manage to move the market for its stock. We did some...
Mise à jour du récit • Feb 05
HYPE3: Index Exit And Higher Margin Outlook Will Support Future Upside
Analysts have slightly reduced their price target on Hypera to reflect updated assumptions on fair value, revenue growth, profit margin and future P/E, while keeping the overall outlook broadly consistent with prior estimates. What's in the News Hypera S.A. removed from the Brazil IBRX 50 Index, which may affect how index-linked funds and some institutional investors are exposed to the stock (Key Developments).Mise à jour du récit • Jan 20
HYPE3: Slight Index Exit And Firm P/E Outlook Will Support Upside
Analysts have nudged their price target for Hypera slightly lower to reflect small adjustments in fair value, discount rate, revenue growth, profit margin and future P/E assumptions, resulting in a modest trim of about R$0.15 per share. What's in the News Hypera S.A. removed from the Brazil IBRX 50 Index, which may affect how some index and benchmark aware investors treat the stock (Key Developments).Mise à jour du récit • Jan 05
HYPE3: Future P/E Multiple Expansion Will Support Further Upside Potential
Analysts have slightly increased their price target on Hypera to reflect updated fair value estimates and adjustments to revenue growth, profit margin expectations, and future P/E assumptions. What's in the News Hypera S.A. is scheduled to hold a board meeting on Dec 11, 2025, which may address governance, capital allocation, or operational planning (company event filing).Article d’analyse • Dec 28
Hypera (BVMF:HYPE3) Takes On Some Risk With Its Use Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Mise à jour du récit • Dec 15
HYPE3: Future P E Expansion Will Support Further Upside Potential
Analysts have slightly raised their price target on Hypera to $30.24 from $30.14, citing modestly stronger revenue growth expectations that more than offset a small downward revision in projected profit margins and a higher implied future P/E multiple. Valuation Changes Fair Value Estimate has risen slightly from R$30.14 to R$30.24 per share, reflecting a modestly higher intrinsic valuation.Article d’analyse • Dec 01
What You Can Learn From Hypera S.A.'s (BVMF:HYPE3) P/E
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 9x, you may consider Hypera...Mise à jour du récit • Dec 01
HYPE3: Future P/E Expansion Signals Continued Upside Potential
Analysts have increased their price target for Hypera from $29.59 to $30.14, citing revised estimates that reflect a slightly higher discount rate as well as updated projections for revenue growth and profit margin. Valuation Changes Fair Value: Increased slightly from R$29.59 to R$30.14 per share.Article d’analyse • Nov 05
Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think
Hypera S.A.'s ( BVMF:HYPE3 ) stock showed strength, with investors undeterred by its weak earnings report. We think...Article d’analyse • Sep 05
Does Hypera (BVMF:HYPE3) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Aug 10
Hypera S.A. Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next
It's been a sad week for Hypera S.A. ( BVMF:HYPE3 ), who've watched their investment drop 10% to R$23.19 in the week...Article d’analyse • Jun 15
The Price Is Right For Hypera S.A. (BVMF:HYPE3)
With a price-to-earnings (or "P/E") ratio of 21.7x Hypera S.A. ( BVMF:HYPE3 ) may be sending very bearish signals at...Article d’analyse • Apr 23
Does Hypera (BVMF:HYPE3) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Mar 27
Hypera's (BVMF:HYPE3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Hypera S.A.'s ( BVMF:HYPE3 ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
Nouveau récit • Mar 23
Product Expansion And Investments In Chronic Treatments Will Strengthen Future Operations
Hypera's working capital focus will improve cash flow, enhancing net margins and financial stability through inventory and operational efficiency enhancements.Article d’analyse • Feb 24
Why Investors Shouldn't Be Surprised By Hypera S.A.'s (BVMF:HYPE3) P/E
With a median price-to-earnings (or "P/E") ratio of close to 8x in Brazil, you could be forgiven for feeling...Article d’analyse • Nov 21
More Unpleasant Surprises Could Be In Store For Hypera S.A.'s (BVMF:HYPE3) Shares After Tumbling 27%
To the annoyance of some shareholders, Hypera S.A. ( BVMF:HYPE3 ) shares are down a considerable 27% in the last month...Article d’analyse • Nov 14
We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Article d’analyse • Oct 03
Investors Appear Satisfied With Hypera S.A.'s (BVMF:HYPE3) Prospects
There wouldn't be many who think Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 10x is worth a...Article d’analyse • Jul 13
We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Jun 20
Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing
It's not a stretch to say that Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 10.9x right now seems...Article d’analyse • Mar 16
Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Investors in Hypera S.A. ( BVMF:HYPE3 ) had a good week, as its shares rose 3.3% to close at R$34.10 following the...Article d’analyse • Feb 21
Is Hypera (BVMF:HYPE3) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Jan 09
Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Article d’analyse • Dec 22
Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price
It's not a stretch to say that Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 12.7x right now seems...Article d’analyse • Nov 02
Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Article d’analyse • Aug 27
Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Article d’analyse • Jul 21
Is Hypera (BVMF:HYPE3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Apr 15
We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Feb 19
With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Article d’analyse • Jan 03
We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Oct 11
Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Article d’analyse • Jul 31
Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
It's been a good week for Hypera S.A. ( BVMF:HYPE3 ) shareholders, because the company has just released its latest...Article d’analyse • Jul 19
Is Hypera (BVMF:HYPE3) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Jun 28
Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Article d’analyse • Apr 14
Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Article d’analyse • Mar 25
I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Article d’analyse • Mar 04
Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price
Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 13x might make it look like a sell right now...Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Hypera gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 7,699 | 1,196 | 2,795 | 0 |
| 30 Sep 25 | 6,973 | 825 | 2,793 | 0 |
| 30 Jun 25 | 6,662 | 746 | 2,800 | 0 |
| 31 Mar 25 | 6,697 | 811 | 2,821 | 0 |
| 31 Dec 24 | 7,442 | 1,343 | 2,654 | 0 |
| 30 Sep 24 | 7,778 | 1,570 | 2,548 | 0 |
| 30 Jun 24 | 8,001 | 1,693 | 2,507 | 0 |
| 31 Mar 24 | 8,043 | 1,704 | 2,511 | 0 |
| 31 Dec 23 | 7,915 | 1,649 | 2,521 | 0 |
| 30 Sep 23 | 8,189 | 1,772 | 2,531 | 0 |
| 30 Jun 23 | 8,086 | 1,741 | 2,492 | 0 |
| 31 Mar 23 | 7,751 | 1,694 | 2,375 | 0 |
| 31 Dec 22 | 7,546 | 1,705 | 2,299 | 0 |
| 30 Sep 22 | 7,051 | 1,640 | 2,121 | 0 |
| 30 Jun 22 | 6,648 | 1,636 | 2,017 | 0 |
| 31 Mar 22 | 6,260 | 1,660 | 1,955 | 0 |
| 31 Dec 21 | 5,937 | 1,618 | 1,895 | 0 |
| 30 Sep 21 | 5,446 | 1,577 | 1,872 | 0 |
| 30 Jun 21 | 4,902 | 1,462 | 1,756 | 0 |
| 31 Mar 21 | 4,445 | 1,382 | 1,626 | 0 |
| 31 Dec 20 | 4,089 | 1,322 | 1,564 | 0 |
| 30 Sep 20 | 3,883 | 1,243 | 1,538 | 0 |
| 30 Jun 20 | 3,803 | 1,165 | 1,605 | 0 |
| 31 Mar 20 | 3,726 | 1,106 | 1,635 | 0 |
| 31 Dec 19 | 3,295 | 1,189 | 1,611 | 0 |
| 30 Sep 19 | 3,294 | 1,252 | 1,558 | 0 |
| 30 Jun 19 | 3,233 | 1,225 | 1,508 | 0 |
| 31 Mar 19 | 3,180 | 1,164 | 1,469 | 0 |
| 31 Dec 18 | 3,724 | 1,135 | 1,481 | 0 |
| 30 Sep 18 | 3,789 | 1,288 | 1,508 | 0 |
| 30 Jun 18 | 3,716 | 1,251 | 1,477 | 0 |
| 31 Mar 18 | 3,613 | 1,200 | 1,430 | 0 |
| 31 Dec 17 | 3,500 | 1,111 | 1,410 | 0 |
| 30 Sep 17 | 3,291 | 819 | 1,397 | 0 |
| 30 Jun 17 | 3,226 | 795 | 1,380 | 0 |
| 31 Mar 17 | 3,216 | 743 | 1,394 | 0 |
| 31 Dec 16 | 3,228 | 647 | 1,372 | 0 |
| 30 Sep 16 | 3,202 | 557 | 1,360 | 0 |
| 30 Jun 16 | 3,129 | 432 | 1,339 | 0 |
| 31 Mar 16 | 3,046 | 349 | 1,323 | 0 |
| 31 Dec 15 | 2,957 | 345 | 1,307 | 0 |
| 30 Sep 15 | 1,589 | 263 | 774 | 0 |
| 30 Jun 15 | 2,039 | 326 | 944 | 0 |
Des revenus de qualité: HYPE3 a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de HYPE3 sont inférieures à celles de l'année dernière HYPE3. (15.5%) sont inférieures à celles de l'année dernière (18%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de HYPE3 ont diminué de 6.8% par an au cours des 5 dernières années.
Accélération de la croissance: HYPE3 a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: HYPE3 a enregistré une croissance négative de ses bénéfices ( -10.9% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Pharmaceuticals ( 8.1% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de HYPE3 ( 9.5% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/28 18:03 |
| Cours de l'action en fin de journée | 2026/05/27 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Hypera S.A. est couverte par 22 analystes. 12 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Andréa Aznar | BB Banco de Investimento S.A. |
| Robert Ford Aguilar | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |